Evidence map›Paper›PMID 27707790›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Landscape of Genomic Alterations in Pituitary Adenomas.

Wenya Linda Bi, Peleg Horowitz, Noah F Greenwald, Malak Abedalthagafi, Pankaj K Agarwalla, Wiliam J Gibson, Yu Mei, Steven E Schumacher, Uri Ben-David, Aaron Chevalier and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 130 citations in OpenAlex.

  1. Article
  2. Pathogenesis of nonfamilial somatotroph adenomas.The Journal of clinical endocrinology and metabolism · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. DNA Methylation in Pituitary Adenomas: A Scoping Review.International journal of molecular sciences · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 2 countries.

Wenya Linda BiDepartment of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Peleg HorowitzDepartment of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Noah F GreenwaldDepartment of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Malak AbedalthagafiDepartment of Pathology, Division of Neuropathology, Brigham and Women's Hospital, Boston, Massachusetts.
Pankaj K AgarwallaDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Wiliam J GibsonDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Yu MeiDepartment of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Steven E SchumacherBroad Institute of MIT and Harvard, Cambridge, Massachusetts.
Uri Ben-DavidBroad Institute of MIT and Harvard, Cambridge, Massachusetts.
Aaron ChevalierBroad Institute of MIT and Harvard, Cambridge, Massachusetts.
Scott CarterBroad Institute of MIT and Harvard, Cambridge, Massachusetts.
Grace TiaoBroad Institute of MIT and Harvard, Cambridge, Massachusetts.
Priscilla K BrastianosDepartment of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Azra H LigonClinical Cytogenetics Laboratory, Brigham and Women's Hospital, Boston, Massachusetts.
Matthew DucarCenter for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts.
Laura MacConaillCenter for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts.
Edward R LawsDepartment of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Sandro SantagataDepartment of Pathology, Division of Neuropathology, Brigham and Women's Hospital, Boston, Massachusetts.
Rameen BeroukhimDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. idunn@partners.org Rameen_Beroukhim@dfci.harvard.edu.
Ian F DunnDepartment of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. idunn@partners.org Rameen_Beroukhim@dfci.harvard.edu.
Broad Institute · USBrigham and Women's Hospital · USDana-Farber Cancer Institute · USMassachusetts General Hospital · US

Funding

Genetic evolution of glioblastomas during radiation and temozolomide therapyR01CA188228 · NCI · DANA-FARBER CANCER INST · PI BEROUKHIM, RAMEEN, CHAKRAVARTI, ARNAB · 2015 to 2025
$6.9M
High-resolution genome-wide mapping of structural mutations in prostate cancerK08CA122833 · NCI · DANA-FARBER CANCER INST · PI BEROUKHIM, RAMEEN · 2007 to 2011
$697k
Hemizygous deletion of esential genes enables a novel therqpeutic vulnerability in cancerF30CA192725 · NCI · HARVARD MEDICAL SCHOOL · PI GIBSON, WILLIAM J · 2015 to 2017
$121k
NCI NIH HHS F30 CA192725NCI NIH HHS K08 CA122833NCI NIH HHS R01 CA188228
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Exome SequencingAdultAgedAged, 80 and overBrain NeoplasmsChromosomes, HumanDNA Copy Number VariationsFemaleGene Expression Regulation, NeoplasticGenome, HumanHumansINDEL MutationMaleMiddle AgedMutationPituitary Neoplasms

Identifiers

PMID27707790
PMCPMC5380512
OpenAlexW2528324838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.